Head-to-head · WeighScore
Fitstry vs This Gen Wellness
The verdict
Fitstry takes it — 61.5/100 to 56.9/100.
Fitstry grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fitstry is the GLP-1 weight-loss program of Weightstry, LLC, a LegitScript-certified, cash-pay telehealth practice focused on women 40+.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Fitstry | This Gen Wellness |
|---|---|---|
| WeighScore | 61.5/100 | 56.9/100 |
| Grade | C | C |
| Scorecard rank | #292 | #405 |
| Semaglutide | $179/mo (annual plan, plus a separate fee, compounded) | Not disclosed |
| Tirzepatide | $269/mo (annual plan, compounded) | Not disclosed |
| Coverage | Coverage not published | 1 state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #292 · C
Strengths
- Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
- Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
- Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
- Runs under Weightstry, LLC, a LegitScript-certified practice with an independently verifiable seal, a named support email and phone
- Full compounded lineup — weekly injection, daily oral tablet and microdosing options
Where it loses points
- Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Framed for women 40+, and serves 49 states rather than all 50 (the excluded state isn't disclosed publicly)
- Works with state-licensed compounding pharmacies but doesn't name a specific pharmacy partner on the Fitstry page
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Graded #405 · C
Strengths
- Requires a synchronous live audio-video visit with a New York-licensed clinician — prescriptions are never issued from the intake form alone
- Assessment and clinician review are free; you only pay if treatment is prescribed and you choose to proceed
- Names its legal entity (ThisGen, LLC) and specifies New York governing law in its terms
- No long-term contracts — plans can be paused or stopped
- The same clinician follows your care, with ongoing secure messaging between visits
Where it loses points
- Publishes no prices at all — 'We don't list flat prices on the website'; cost is disclosed only after a clinician reviews your assessment
- Serves New York only — 'we currently operate exclusively for patients located in New York'
- Dispensing pharmacies are not named, only described as 'licensed U.S. pharmacies'
- Does not state whether its semaglutide and tirzepatide are compounded or brand-name
- Does not bill insurance; verifying any reimbursement is the patient's responsibility
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.